Hiromasa Harada
- Co-authors
- Thomas A. RaffinAkitoshi IshizakaMakoto YonemaruCraig M. LillyKenton E. StephensZhaohan WuJames W. LarrickJ. Robert Hatherill
- Topics
- SARS-CoV-2 and COVID-19 Research (2 papers)Drug Transport and Resistance Mechanisms (2 papers)Eosinophilic Disorders and Syndromes (2 papers)
- Partner nations
- JapanUnited StatesBangladesh
In The Last Decade
Hiromasa Harada
19 papers receiving 430 citations
Peers
Comparison fields: 5 of 80
- Pulmonary and Respiratory Medicine 152
- Immunology 109
- Epidemiology 85
- Molecular Biology 64
- Oncology 64
Countries citing papers authored by Hiromasa Harada
This map shows the geographic impact of Hiromasa Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromasa Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromasa Harada more than expected).
Fields of papers citing papers by Hiromasa Harada
This network shows the impact of papers produced by Hiromasa Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromasa Harada. The network helps show where Hiromasa Harada may publish in the future.
Co-authorship network of co-authors of Hiromasa Harada
This figure shows the co-authorship network connecting the top 25 collaborators of Hiromasa Harada. A scholar is included among the top collaborators of Hiromasa Harada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromasa Harada. Hiromasa Harada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 16 | |
| 3 | 2 | |
| 4 | 12 | |
| 5 | 11 | |
| 6 | 18 | |
| 7 | 16 | |
| 8 | 0 | |
| 9 | 12 | |
| 10 | 10 | |
| 11 | [Hyponatremia caused by pituitary metastasis of lung cancer]. | 2 |
| 12 | 2 | |
| 13 | [Pneumatosis cystoides intestinalis in a patient with lung cancer]. | 2 |
| 14 | 36 | |
| 15 | 10 | |
| 16 | 32 | |
| 17 | 13 | |
| 18 | 103 | |
| 19 | 55 | |
| 20 | 81 |
About Hiromasa Harada
Hiromasa Harada is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Neurology, having authored 20 papers that have together received 438 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Eosinophilic Disorders and Syndromes (2 papers). The work is most often cited by research in Immunology (109 citations), Pulmonary and Respiratory Medicine (152 citations) and Critical Care and Intensive Care Medicine (20 citations). Hiromasa Harada has collaborated with scholars based in Japan, United States and Bangladesh. Frequent co-authors include Thomas A. Raffin, Akitoshi Ishizaka, Makoto Yonemaru, Craig M. Lilly, Kenton E. Stephens, Zhaohan Wu, James W. Larrick, J. Robert Hatherill, Hans Hoffmann and Jeffrey Crowley. Their work appears in journals such as Scientific Reports, Annals of Oncology and Clinical Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.